- Overview
- Key stats
- Stock price
- Financial performance
- Growth
- Valuations
- Efficiency
- Dividends
- Financial health
- Stocks
- Real Estate
- NYSE: GMRE
Price (delayed)
$7.81
Market cap
$522.26M
P/E Ratio
781
Dividend/share
$0.84
EPS
$0.01
Enterprise value
$1.16B
Global Medical REIT Inc. is a net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market ...
Highlights
The EPS has surged by 150% since the previous quarter but it has dropped by 96% year-on-year
The company's net income has shrunk by 68% YoY but it has surged by 50% QoQ
The equity has declined by 8% year-on-year
GMRE's debt is up by 6% YoY and by 2.7% QoQ
Key stats
What are the main financial stats of GMRE
MarketValuationsEarnings
Shares outstanding
66.87M
Market cap
$522.26M
Enterprise value
$1.16B
Price to earnings (P/E)
781
Price to book (P/B)
0.98
Price to sales (P/S)
3.71
EV/EBIT
32.83
EV/EBITDA
15.31
EV/Sales
8.35
Revenue
$138.78M
Gross profit
$138.78M
Operating income
$32.89M
Net income
$6.63M
EBIT
$35.32M
EBITDA
$75.75M
Free cash flow
$32.01M
Per shareBalance sheetLiquidity
EPS
$0.01
EPS diluted
$0.01
Free cash flow per share
$0.49
Book value per share
$8
Revenue per share
$2.1
TBVPS
$18.97
Total assets
$1.26B
Total liabilities
$700.57M
Debt
$646.13M
Equity
$534.13M
Working capital
N/A
Debt to equity
1.21
Current ratio
N/A
Quick ratio
N/A
Net debt/EBITDA
8.41
MarginsEfficiencyDividend
EBITDA margin
54.6%
Gross margin
100%
Net margin
4.8%
Operating margin
23.7%
Return on assets
0.1%
Return on equity
0.1%
Return on invested capital
1.9%
Return on capital employed
N/A
Return on sales
25.5%
Dividend yield
10.76%
DPS
$0.84
Payout ratio
8,400%
GMRE stock price
How has the Global Medical REIT stock price performed over time
Intraday
1.43%
1 week
1.56%
1 month
-9.08%
1 year
-6.24%
YTD
1.17%
QTD
-10.74%
Financial performance
How have Global Medical REIT's revenue and profit performed over time
Revenue
$138.78M
Gross profit
$138.78M
Operating income
$32.89M
Net income
$6.63M
Gross margin
100%
Net margin
4.8%
GMRE financials
The company's net income has shrunk by 68% YoY but it has surged by 50% QoQ
GMRE's net margin has shrunk by 67% YoY but it has soared by 50% QoQ
GMRE's operating income is down by 13% year-on-year and by 6% since the previous quarter
The operating margin is down by 12% year-on-year and by 7% since the previous quarter
Price vs fundamentals
Earnings waterfall
Growth
What is Global Medical REIT's growth rate over time
GMRE growth chart
Valuation
What is Global Medical REIT stock price valuation
P/E
781
P/B
0.98
P/S
3.71
EV/EBIT
32.83
EV/EBITDA
15.31
EV/Sales
8.35
Valuation vs average
Price to earnings (P/E)
The EPS has surged by 150% since the previous quarter but it has dropped by 96% year-on-year
Price to book (P/B)
The P/B is 18% lower than the 5-year quarterly average of 1.2 and 11% lower than the last 4 quarters average of 1.1
The equity has declined by 8% year-on-year
Price to sales (P/S)
The stock's price to sales (P/S) is 36% less than its 5-year quarterly average of 5.8 and 12% less than its last 4 quarters average of 4.2
Efficiency
How efficient is Global Medical REIT business performance
GMRE's ROA has soared by 200% QoQ but it has shrunk by 91% YoY
The ROE has soared by 150% QoQ but it has shrunk by 96% YoY
The return on sales has declined by 30% year-on-year but it rose by 7% since the previous quarter
GMRE's return on invested capital is down by 30% year-on-year but it is up by 6% since the previous quarter
Dividends
What is GMRE's dividend history
DPS
$0.84
Dividend yield
10.76%
Payout ratio
8,400%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Global Medical REIT financials performed over time
Assets vs liabilities
The company's total assets is 79% higher than its total liabilities
The total liabilities is up by 6% year-on-year and by 3.3% since the previous quarter
Debt vs equity
GMRE's debt is 21% higher than its equity
The debt to equity rose by 15% year-on-year and by 4.3% since the previous quarter
The equity has declined by 8% year-on-year
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.